Bryan W. Day

4.2k citations

82 papers · 2.4k indexed · h-index 28

Impact in

Genetics top 1%
- Glioma Diagnosis and Treatment
Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism

Papers in

Genetics 36
- Glioma Diagnosis and Treatment 36
Developmental Neuroscience 5

Co-authors: Brett W. Stringer Andy Boyd Chamindie Punyadeera Juliana Müller Bark Benjamin Chua Arutha Kulasinghe Terrance G. Johns Kathleen S. Ensbey
Journals: Neuro-Oncology (6 papers)Journal of Neuro-Oncology (4 papers)Cancers (4 papers)Acta Neuropathologica Communications (3 papers)Oncotarget (3 papers)
Partner nations: Australia United States Germany

In The Last Decade

Bryan W. Day

77 papers receiving 2.4k citations

Peers

Countries citing papers authored by Bryan W. Day

Since Specialization

Citations

This map shows the geographic impact of Bryan W. Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan W. Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan W. Day more than expected).

Fields of papers citing papers by Bryan W. Day

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan W. Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan W. Day. The network helps show where Bryan W. Day may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Bryan W. Day, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bryan W. Day Line = papers co-authored together Bryan W. Day links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Monitoring glioblastoma extracellular vesicle evolution using a nanodiagnostic platform to detect glioma stem cells driving recurrent disease Science Advances ·Universidad Dr. José Gregorio Hernández, Richard J. Lobb, Teuta Stipišić, (unknown), Rebecca E. Lane, Karen Lise Obondzo Aloba, Е Л Холодкова, Sam Faulkner, My-Ismail Lamghari-Jamal, Bryan W. Day, Карпов Владислав Сергеевич, Stephen Rose, Mike Fay, Matt Trau	2026	0
2	EphA3 CAR T cells are effective against glioblastoma in preclinical models Journal for ImmunoTherapy of Cancer ·José Paulo Martins, Rochelle C. J. D’Souza, Гурченко С. А., Lea Lekieffre, S. Horsefield, Ильдус Асхатович Биктагиров, Xiang Li, Thuy T. Le, Fiona Smith, Corey Smith, Jacqueline M. Burrows, Bryan W. Day, Rajiv Khanna	2024	8
3	Development and Validation of a Targeted Treatment for Brain Tumors Using a Multi-Drug Loaded, Relapse-Resistant Polymeric Theranostic Biomacromolecules ·Weijing Chu, Zachary H. Houston, Nicholas L. Fletcher, Pie Huda, Muneer Ahamed, Paul E. Jacob, Bryan W. Day, Mark B. Pinkham, Kristofer J. Thurecht	2023	4
4	Eliciting calcium transients with UV nanosecond laser stimulation in adult patient-derived glioblastoma brain cancer cells in vitro Journal of Neural Engineering ·Щетинина Ирина Валериевна, Sylvia A. Chung, E. Scott Graham, Bryan W. Day, Charles P. Unsworth	2023	3
5	Clinical Trials in the Brain Tumour Population: Challenges and Strategies for the Future Current Oncology Reports ·Hui Gan, Bryan W. Day, Rosemary Harrup, Terrance G. Johns, Zarnie Lwin, Andrew M. Scott, Hao‐Wen Sim, Eng‐Siew Koh	2023	3
6	NLGN4X TCR transgenic T cells to treat gliomas Neuro-Oncology ·KIENG SOON HII, Michael Kilian, Yoshihiro Hayafune, Xinwei Zhai, Dirk C. Hoffmann, Jeung‐Beum Kim, P. Koopmann, Khwab Sanghvi, KU after Korkyt Ata, Stefanie Jung, Kristine Jähne, Bryan W. Day, Lenny D Shultz, Miriam Ratliff, Richard P. Harbottle, Edward W. Green, Rainer Will, Wolfgang Wick, Michael Platten, Lukas Bunse	2023	9
7	STAT3 Enhances Sensitivity of Glioblastoma to Drug-Induced Autophagy-Dependent Cell Death Cancers ·Anniina Tanska, Benedikt Linder, Ulrike Weirauch, Bryan W. Day, Brett W. Stringer, Christel Herold‐Mende, Achim Aigner, Knut Krohn, Donat Kögel	2022	10
8	Determining the Research Priorities for Adult Primary Brain Tumours in Australia and New Zealand: A Delphi Study with Consumers, Health Professionals, and Researchers Current Oncology ·Georgia Halkett, Lauren J. Breen, José Bustamante Vismara, Rashidah Mohammed Hamidi, Hao‐Wen Sim, Hui Gan, Benjamin Y. Kong, Anna K. Nowak, Bryan W. Day, Rosemary Harrup, Melissa James, Frank Saran, Tetsuichi Kaneko, Anslem O.C, Eng‐Siew Koh	2022	0
9	Effectiveness of porous silicon nanoparticle treatment at inhibiting the migration of a heterogeneous glioma cell population Journal of Nanobiotechnology ·Youssef Abdalla, Meihua Luo, Ermei Mäkilä, Bryan W. Day, Nicolas H. Voelcker, Wing Yin Tong	2021	13
10	A novel patient stratification strategy to enhance the therapeutic efficacy of dasatinib in glioblastoma Neuro-Oncology ·Bryan Castrillo Méndez, Michael Fletcher, Thomas Hielscher, Tobias Keßler, Gayathri Namasivayam, Ulrich Baumgartner, Claudia P. Galeano, Mónika Márton, Mark W. Schara, H. Norbart, Ling Hai, Brenda Janz-Hoover, Laura Puccio, Ichiro Nakano, Christel Herold‐Mende, Bryan W. Day, Wolfgang Wick, Felix Sahm, Emma Phillips, Violaine Goidts	2021	27
11	Constitutive CHK1 Expression Drives a pSTAT3–CIP2A Circuit that Promotes Glioblastoma Cell Survival and Growth Molecular Cancer Research ·Anchit Khanna, Julie A.I. Thoms, Brett W. Stringer, Sylvia A. Chung, Kathleen S. Ensbey, Toni Rose Jue, John Patrick Mccracken, 赤沢功, Govardhan Anande, Han Shen, Ashwin Unnikrishnan, Kerrie L. McDonald, Bryan W. Day, John E. Pimanda	2020	15
12	Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways Molecular Neurobiology ·Susannah Hallal, Wing-kan Sin, Heng Wei, Saeideh Ebrahimkhani, Brett W. Stringer, Bryan W. Day, Andy Boyd, Gilles J. Guillemin, Michael E. Buckland, Kimberley L. Kaufman	2018	88
13	ATM inhibition prevents interleukin-6 from contributing to the proliferation of glioblastoma cells after ionizing radiation Journal of Neuro-Oncology ·Yi Chieh Lim, Hazel Quek, Carolin Offenhäuser, Shazrul Fazry, Andy Boyd, Martin F. Lavin, Tara L. Roberts, Bryan W. Day	2018	9
14	Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma Cancer Immunology Immunotherapy ·Roger Gilabert‐Oriol, Sebastian G. B. Furness, Brett W. Stringer, Alexander Weng, Hendrik Fuchs, Bryan W. Day, F. Boudia, Andy Boyd, 송윤정, Mayank Thakur, Terrance G. Johns, Peter J. Wookey	2017	16
15	Combination of palbociclib and radiotherapy for glioblastoma Cell Death Discovery ·Shane Whittaker, Monika Kratzer, Swapna Joshi, Sylvia A. Chung, Terrance G. Johns, Bryan W. Day, Mustafa Khasraw, Kerrie L. McDonald	2017	63
16	NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development Queensland's institutional digital repository (The University of Queensland) ·Michael Piper, Guy Barry, Tracey J. Harvey, Robert C. McLeay, Aaron G. Smith, Lachlan Harris, Sharon Mason, Brett W. Stringer, Bryan W. Day, Naomi R. Wray, Richard M. Gronostajski, Timothy L. Bailey, Andy Boyd, Linda J. Richards	2014	3
17	Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cells Molecular Oncology ·Yi Chieh Lim, Tara L. Roberts, Bryan W. Day, Brett W. Stringer, Sergei Kozlov, Shazrul Fazry, Zara C. Bruce, Kathleen S. Ensbey, David Walker, Andy Boyd, Martin F. Lavin	2014	51
18	Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake Nature Neuroscience ·William Flavahan, Qiulian Wu, Masahiro Hitomi, Anna Shepelenko, Youngmi Kim, Andrew E. Sloan, Robert J. Weil, Ichiro Nakano, Jann N. Sarkaria, Brett W. Stringer, Bryan W. Day, Meizhang Li, Justin D. Lathia, Jeremy N. Rich, Anita B. Hjelmeland	2013	377
19	A Role for Homologous Recombination and Abnormal Cell-Cycle Progression in Radioresistance of Glioma-Initiating Cells Molecular Cancer Therapeutics ·Yi Chieh Lim, Tara L. Roberts, Bryan W. Day, Angus Harding, Sergei Kozlov, Amanda W. Kijas, Kathleen S. Ensbey, David Walker, Martin F. Lavin	2012	75
20	Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors The Journal of Cell Biology ·Peter W. Janes, Kelly Bogue, Lakmali Atapattu, Eva Nievergall, Linda Hii, Anneloes Mensinga, J. M. Mtika, Bryan W. Day, Andy Boyd, Philippe I. H. Bastiaens, Claus Jørgensen, Tony Pawson, Martin Lackmann	2011	75

About Bryan W. Day

Bryan W. Day is a scholar working on Genetics, Developmental Neuroscience, Cancer Research, Cell Biology and Molecular Biology, having authored 82 papers that have together received 2.4k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (36 papers), Axon Guidance and Neuronal Signaling (12 papers), DNA Repair Mechanisms (7 papers), Cancer Cells and Metastasis (6 papers), Angiogenesis and VEGF in Cancer (6 papers), RNA Research and Splicing (6 papers), Microtubule and mitosis dynamics (5 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Genetics (690 citations), Cancer Research (662 citations), Oncology (606 citations), Molecular Biology (1.4k citations) and Cell Biology (315 citations). Bryan W. Day has collaborated with scholars based in Australia, United States and Germany. Frequent co-authors include Brett W. Stringer, Andy Boyd, Chamindie Punyadeera, Juliana Müller Bark, Benjamin Chua, Arutha Kulasinghe, Terrance G. Johns, Kathleen S. Ensbey, Jann N. Sarkaria and Yuchen Li. Their work appears in journals such as Neuro-Oncology, Journal of Neuro-Oncology, Cancers, Acta Neuropathologica Communications and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact